Molecular Pathogenesis of Inherited Platelet Dysfunction

Area of Science:

• Hematology
• Molecular Genetics
• Human Physiology

Background:

• Inherited platelet function disorders (IPFDs) are genetic conditions with normal platelet counts but impaired function.
• Glanzmann's thrombasthenia, a key IPFD, stems from mutations in genes for the αIIbβ3 integrin complex, causing severe bleeding.
• The spectrum of IPFDs includes defects in platelet receptors, signaling proteins, and granule biogenesis.

Purpose of the Study:

• To review the molecular basis, clinical features, and management of IPFDs.
• To highlight the impact of advanced sequencing technologies on IPFD diagnosis and understanding.
• To discuss emerging therapeutic strategies and their implications for platelet biology.

Main Methods:

• Review of current literature on IPFDs.
• Analysis of genetic variants and their correlation with clinical phenotypes.
• Examination of diagnostic and therapeutic advancements.

Main Results:

• Molecular genetics has identified numerous genes associated with IPFDs beyond Glanzmann's thrombasthenia.
• High-throughput sequencing significantly enhances diagnostic accuracy and genotype-phenotype correlation.
• Current management includes antifibrinolytics, desmopressin, and platelet transfusions, with gene therapy and bispecific antibodies as emerging options.

Conclusions:

• Understanding IPFD molecular pathogenesis is crucial for precise diagnosis and effective treatment.
• Advanced genetic tools are revolutionizing the study and management of platelet function disorders.
• Future research directions include gene therapy and novel antibody-based treatments for improved patient outcomes.